Chukwuka Okafor, MD
Orthopaedic Surgery of the Spine · Lakeland, FLNPI 1699979534
Payments from drug & device makers
What this record shows
This record is dominated by other: $56,680 of the $57,630 with a category attached, or 98.4%. Medtronic accounts for 98.4% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $56,841, more than ten times the $110 reported in 2019.
Across 13 payments — averaging $4433.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$57K
- Medacta USA, Inc.$509
- Biotronik NRO, Inc.$129
- AstraZeneca$111
- Zimmer Biomet$110
- Johnson & Johnson$36
- plus $55 from 3 others
What the payments were for
- Travel & lodging$3271%
- Food & beverage$6221%
- Other$56,68098%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $56,680 |
| Medacta USA, Inc. | 4 | $509 |
| Biotronik NRO, Inc. | 1 | $129 |
| AstraZeneca | 1 | $111 |
| Zimmer Biomet | 1 | $110 |
| Johnson & Johnson | 2 | $36 |
| Boston Scientific | 1 | $29 |
| Coastal Medical Technologies LLC | 1 | $23 |
| Spineology Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMISTEM$246
- Prospera$129
- FARXIGA$111
- Surgical Product Portfolio$110
How this compares
$57,630 in reported general payments places this provider in the 65th percentile of 159 orthopaedic surgery of the spine providers in Florida.
See all orthopaedic surgery of the spine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $698 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $662 |
| Pregabalin | 22 | $411 |
| Cyclobenzaprine Hcl | 129 | $396 |
| Methylprednisolone | 36 | $232 |
| Cefadroxil | 33 | $218 |
| Gabapentin | 27 | $216 |
| Cephalexin | 52 | $203 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 38 | $181 |
| Doxycycline Hyclate | 33 | $161 |
| Tizanidine Hcl | 27 | $108 |
| Meloxicam | 24 | $73 |
| Clindamycin Hcl | 21 | $66 |
| Levofloxacin | 23 | $53 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Lakeland
- Harry ShufflebargerMiami$3.5M
- Paul KellerMelbourne$3.4M
- Thomas SweeneySarasota$2.3M
- Geoffrey CronenTampa$2.2M
- James BillysOdessa$1.9M
- Mark DekutoskiDestin$1.8M
- Farhan SiddiqiOdessa$1.7M
- Samuel JosephSafety Harbor$1.7M
- Thomas ErricoMiami$1.6M
- Constantine ToumbisCrystal River$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.